Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

Cytokine and Growth Factor Reviews

Volumn 17, Issue 5, 2006, Pages 367-380

  Wolk, Kerstin ^a   Sabat, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CRF2; Cytokine receptors; Cytokines; IL 10 family; IL 22 binding protein

Indexed keywords

BINDING PROTEIN; CYTOKINE; INTERLEUKIN 22; INTERLEUKIN 22 BINDING PROTEIN; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIGESTIVE SYSTEM; FUNCTIONAL PROTEOMICS; HOMEOSTASIS; HUMAN; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; IMMUNOGENETICS; KIDNEY; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SKIN CULTURE; T LYMPHOCYTE; TISSUE CULTURE; TISSUE INJURY;

HUMANS; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; INTERLEUKINS; KILLER CELLS, NATURAL; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33749983749     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.09.001     Document Type: Review

References (62)

1. Dumoutier L., Louahed J., and Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164 (2000) 1814-1819
2. Dumoutier L., Van Roost E., Colau D., and Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97 (2000) 10144-10149
3. Xie M.H., Aggarwal S., Ho W.H., et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275 (2000) 31335-31339
4. Blumberg H., Conklin D., Xu W.F., et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104 (2001) 9-19
5. Gallagher G., Dickensheets H., Eskdale J., et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1 (2000) 442-450
6. Knappe A., Hor S., Wittmann S., and Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 74 (2000) 3881-3887
7. Jiang H., Lin J.J., Su Z.Z., Goldstein N.I., and Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11 (1995) 2477-2486
8. Volk H., Asadullah K., Gallagher G., Sabat R., and Grutz G. IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol 22 (2001) 414-417
9. Kotenko S.V., Gallagher G., Baurin V.V., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4 (2003) 69-77
10. Sheppard P., Kindsvogel W., Xu W., et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4 (2003) 63-68
11. Donnelly R.P., Sheikh F., Kotenko S.V., and Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76 (2004) 314-321
12. Langer J.A., Cutrone E.C., and Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 15 (2004) 33-48
13. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., and Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22 (2004) 929-979
14. Logsdon N.J., Jones B.C., Josephson K., Cook J., and Walter M.R. Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interferon Cytokine Res 22 (2002) 1099-1112
15. Reineke U., Schneider-Mergener J., Glaser R.W., et al. Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 12 (1999) 242-248
16. Dumoutier L., Van Roost E., Ameye G., Michaux L., and Renauld J.C. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1 (2000) 488-494
17. Kotenko S.V. The family of IL-10-related cytokines and their receptors: related, but to what extent?. Cytokine Growth Factor Rev 13 (2002) 223-240
18. Nagem R.A., Colau D., Dumoutier L., Renauld J.C., Ogata C., and Polikarpov I. Crystal structure of recombinant human interleukin-22. Structure (Camb) 10 (2002) 1051-1062
19. Xu T., Logsdon N.J., and Walter M.R. Structure of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr 61 (2005) 942-950
20. Chang C., Magracheva E., Kozlov S., et al. Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278 (2003) 3308-3313
21. Walter M.R., and Nagabhushan T.L. Crystal structure of interleukin 10 reveals an interferon gamma-like fold. Biochemistry 34 (1995) 12118-12125
22. Zdanov A., Schalk-Hihi C., Gustchina A., Tsang M., Weatherbee J., and Wlodawer A. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 3 (1995) 591-601
23. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276 (2001) 2725-2732
24. Logsdon N.J., Jones B.C., Allman J.C., et al. The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation. J Mol Biol 342 (2004) 503-514
25. Wolk K., Kunz S., Asadullah K., and Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol 168 (2002) 5397-5402
26. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
27. Wolk K., Witte E., Wallace E., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36 (2006) 1309-1323
28. Wolk K., Witte E., Reineke U., et al. Is there an interaction between interleukin-10 and interleukin-22?. Genes Immun 6 (2005) 8-18
29. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
30. Andoh A., Zhang Z., Inatomi O., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 (2005) 969-984
31. Ikeuchi H., Kuroiwa T., Hiramatsu N., et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52 (2005) 1037-1046
32. Whittington H.A., Armstrong L., Uppington K.M., and Millar A.B. Interleukin-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol 31 (2004) 220-226
33. Kotenko S.V., Krause C.D., Izotova L.S., Pollack B.P., Wu W., and Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16 (1997) 5894-5903
34. Adams RL, Farrah TM, Jelmberg AC, Lok S, Whitemore TE, Patent WO9907848-A1 and U.S. Patent 5,965,704; 1999.
35. Tachiiri A., Imamura R., Wang Y., Fukui M., Umemura M., and Suda T. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun 4 (2003) 153-159
36. Li J., Tomkinson K.N., Tan X.Y., et al. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int Immunopharmacol 4 (2004) 693-708
37. Josephson K., Logsdon N.J., and Walter M.R. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 15 (2001) 35-46
38. Reineke U., Sabat R., Volk H.D., and Schneider-Mergener J. Mapping of the interleukin-10/interleukin-10 receptor combining site. Protein Sci 7 (1998) 951-960
39. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., and Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174 (2005) 3695-3702
40. Lecart S., Morel F., Noraz N., et al. IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. Int Immunol 14 (2002) 1351-1356
41. Aggarwal S., Xie M.H., Maruoka M., Foster J., and Gurney A.L. Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 21 (2001) 1047-1053
42. Parrish-Novak J., Xu W., Brender T., et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277 (2002) 47517-47523
43. Dumoutier L., Lejeune D., Colau D., and Renauld J.C. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 166 (2001) 7090-7095
44. Gruenberg B.H., Schoenemeyer A., Weiss B., et al. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun 2 (2001) 329-334
45. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 166 (2001) 7096-7103
46. Wei C.C., Ho T.W., Liang W.G., Chen G.Y., and Chang M.S. Cloning and characterization of mouse IL-22 binding protein. Genes Immun 4 (2003) 204-211
47. Weiss B., Wolk K., Grunberg B.H., et al. Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun 5 (2004) 330-336
48. Xu W., Presnell S.R., Parrish-Novak J., et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA 98 (2001) 9511-9516
49. Dumoutier L., Leemans C., Lejeune D., Kotenko S.V., and Renauld J.C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167 (2001) 3545-3549
50. Lejeune D., Dumoutier L., Constantinescu S., Kruijer W., Schuringa J.J., and Renauld J.C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277 (2002) 33676-33682
51. Oral H.B., Kotenko S.V., Yilmaz M., et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 36 (2006) 380-388
52. Salazar A., Pinto X., and Mana J. Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest 31 (2001) 1070-1077
53. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
54. Pan H., Hong F., Radaeva S., and Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 1 (2004) 43-49
55. Schroder J.M., and Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63 (2006) 469-486
56. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., and West A.B. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277 (1999) C183-201
57. Dohi T., Ejima C., Kato R., et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 128 (2005) 411-423
58. Hubner G., Brauchle M., Gregor M., and Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease?. Lab Invest 77 (1997) 311-318
59. Grosfeld J.L., Du X., and Williams D.A. Interleukin-11: its biology and prospects for clinical use. JPEN J Parenter Enteral Nutr 23 (1999) S67-S69
60. Murphy M.S. Growth factors and the gastrointestinal tract. Nutrition 14 (1998) 771-774
61. Kalabis J., Patterson M.J., Enders G.H., et al. Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture. FASEB J 17 (2003) 1115-1117
62. Nagakawa H., Shimozato O., Yu L., et al. Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. Scand J Immunol 60 (2004) 449-454